Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Results vary from person to person, and success depends on consistency, proper use, and supportive lifestyle habits
Current Canadian GLP-1 Medications Health Canada has approved several GLP-1 medications that are currently available across Canadian provinces: Ozempic (semaglutide): Injectable medication manufactured by Novo Nordisk Wegovy (semaglutide): Higher-dose injectable formulation from Novo Nordisk Mounjaro (tirzepatide): Weekly injection produced by Eli Lilly Rybelsus (semaglutide): Daily oral tablet approved by Health Canada in April 2020 Impact on Generic Applications The WHO recommendation comes as Health Canada reviews nine generic semaglutide applications following patent expiry on January 4, 2026
Microdosing sits in that gray area where personalization matters more than protocols
For GLP-1 injections from a vial, fixed needle syringes are strongly preferred
For psyllium, this means approximately 1.5 grams (half a standard dose)
US$ 25.81
US$ 20.18
US$ 26.46
US$ 29.62
US$ 29.25
US$ 26.77
US$ 22.26
US$ 27.97
